Fed's Jefferson says he has not thought about whether to stay on as governor after vice chair term ends
Sept 30 (Reuters) - U.S. Federal Reserve vice chair Philip Jefferson said on Tuesday he has not given thought yet to whether he will keep his seat on the Fed's Board of Governors after his vice chair term ends in September 2027.
The decision could influence when President Donald Trump is able to claim a majority of appointees to the central bank's 7-member governing body.
"I have not given thought to that at all. My focus is to do the job that I currently have right now to the best of my ability and to keep my focus on the economy and trying to make the best decisions with regards to monetary policy," Jefferson, an appointee of former President Joe Biden, said at an economics conference in Finland.
He was referring to whether he will keep his job as a governor, with a term that runs until 2036.
Related Articles
Tesla’s 2025 Shareholder Meeting Showdown: Musk’s Leadership and Tesla’s Crossroads
TradingKey - Tesla (TSLA), the electric vehicle leader, will hold its 2025 Annual Shareholder Meeting on November 6. Dubbed by CEO Elon Musk as a moment that will “decide Tesla’s future and shape the world’s,” the event centers on one pivotal question: Will shareholders approve Musk’s proposed $1 T
Uber Q3 Earnings Deep Dive: Delivery Surging Ahead, AV Strategic Layout, Valuation Yet to Reflect Long-Term Value
TradingKey - Uber, a paragon of the sharing economy founded in 2009, has become the leader in the ride-hailing industry, operating mobility, delivery, and freight services across 70+ countries and 15,000+ cities.
What Drove the 'Black Tuesday' Sell-Off? Three Key Factors Behind the U.S. Stock Plunge
TradingKey - On November 4, 2025, U.S. markets suffered a sudden and sharp selloff — dubbed “Black Tuesday” — with the Nasdaq posting its largest single-day drop in a month. The rout unfolded amid growing economic and political instability, as a record-long government shutdown worsened systemic
Novo Nordisk Q3 Earnings Preview: New CEO, Board Overhaul — Can the U.S. Weight-Loss Market Turn Around?
TradingKey - Novo Nordisk (NVO), one of Europe’s pharmaceutical giants and a leader in the weight-loss drug race, will report its Q3 2025 earnings before market open on November 5. Wall Street expects a modest rebound from Q2’s worst growth in four years, but significant pressure on profits remains.
Palantir Q3 2025 Earnings: Blowout Performance Can’t Hide an AI Bubble， Four Growing Risks Behind a Nearly 1,000x Valuation
TradingKey – After the close of trading on November 4, “AI application King” Palantir Technologies (PLTR) reported its third-quarter earnings for fiscal year 2025. Despite a blowout quarter, surging top-line growth, and a flood of commercial orders, the stock plunged in after-hours trading.
